ASeq Newsletter

ASeq Newsletter

VividDx

Aug 04, 2026
∙ Paid

VividDx is building a single cell Raman diagnostics platform.

They’ve just raised $15M and have a new CEO.

The basic idea is described on their site (but leaves out a few steps):

Exclusive Data Access and Proprietary AI Stack

Vivid are not the first to suggest using Raman recently we’ve seen:

  • Pumpkinseed (Protein Sequencing)

  • CanSense (Liquid Biopsy)

  • Primary Biosciences (Protein Sequencing)

  • Armonica (DNA Sequencing)

But I’m unaware of any significant successes here where single molecule or single cell Raman spectra has been shown to have diagnostic value.

But let’s have a dig around and see what we can find…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Nava Whiteford · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture